Pioglitazone API

Pioglitazone API is an active ingredient of drugs used for the treatment of type 2 diabetes. It belongs to the thiazolidinedione class of drugs. By enhancing insulin sensitivity, it helps the body utilize insulin more effectively to lower blood glucose levels. It can be used alone or in combination with other hypoglycemic drugs. Moreover, to a certain extent, it can also improve dyslipidemia, and has a comprehensive regulatory effect on the metabolic disorders of diabetic patients, which is helpful for controlling the progression of the disease and reducing the risk of complications.